Evolution of the Average Target: West Pharmaceutical Services, Inc.

Evolution of the Target Price: West Pharmaceutical Services, Inc.

Changes in Analyst Recommendations: West Pharmaceutical Services, Inc.

6952bb1e1302a22bcf08030a.N_8SevzqnXdTrzapEB2orDTwjbH8STHNt6PSe0BgxUg.BZhiDM-v6ANk91CEQmvA-mCZxt62AFSZwe-IKBYYtn0CumIVjpLUDh7XYw~184b96accc3afbda6c0f6a2ecfd68ea7
07-27 Evercore ISI Adjusts PT on West Pharmaceutical Services to $425 From $410, Maintains Outperform Rating MT
07-27 BNP Paribas Adjusts PT on West Pharmaceutical Services to $459 From $447, Maintains Outperform Rating MT
07-24 Jefferies & Co Adjusts West Pharmaceutical Services PT to $410 From $365, Maintains Buy Rating MT
07-24 Rothschild & Co Redburn Adjusts West Pharmaceutical Services PT to $410 From $353, Maintains Buy Rating MT
07-24 Deutsche Bank Adjusts West Pharmaceutical Services Price Target to $420 From $405, Maintains Buy Rating MT
07-20 Stephens Adjusts West Pharmaceutical Services Price Target to $410 From $360, Maintains Overweight Rating MT
07-15 TD Cowen Adjusts Price Target on West Pharmaceutical Services to $410 From $365, Maintains Buy Rating MT
07-13 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
07-13 BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target MT
07-09 Morgan Stanley Adjusts Price Target on West Pharmaceutical Services to $365 From $325 MT
07-06 Evercore ISI Adjusts Price Target on West Pharmaceutical Services to $410 From $390 MT
07-02 KeyBanc Adjusts PT on West Pharmaceutical Services to $390 From $350, Maintains Overweight Rating MT
06-09 Barclays Upgrades West Pharmaceutical Services to Overweight From Equalweight, Adjusts PT to $400 From $310 MT
05-28 Morgan Stanley Adjusts West Pharmaceutical Services PT to $325 From $315, Keeps Equalweight Rating MT
04-24 Stephens Adjusts Price Target on West Pharmaceutical Services to $360 From $320, Maintains Overweight Rating MT
04-24 Deutsche Bank Adjusts West Pharmaceutical Services PT to $340 From $315, Maintains Buy Rating MT
04-24 Rothschild & Co Redburn Adjusts West Pharmaceutical Services Price Target to $353 From $312, Maintains Buy Rating MT
04-24 Jefferies Adjusts West Pharmaceutical Services Price Target to $365 From $295, Maintains Buy Rating MT
04-24 Citigroup Adjusts West Pharmaceutical Services PT to $400 From $375, Maintains Buy Rating MT
04-24 Evercore ISI Adjusts West Pharmaceutical Services PT to $390 From $320, Maintains Outperform Rating MT
04-24 TD Cowen Adjusts West Pharmaceutical Services PT to $365 From $350, Maintains Buy Rating MT
04-24 Analyst recommendations: IBM, Intel, Tesla, AMD, United Rentals… Zonebourse
04-14 Barclays Adjusts Price Target on West Pharmaceutical Services to $275 From $265, Maintains Equalweight Rating MT
02-17 Rothschild & Co Redburn Adjusts Price Target on West Pharmaceutical Services to $312 From $325, Maintains Buy Rating MT
02-13 Stephens Cuts Price Target on West Pharmaceutical Services to $320 From $350, Maintains Overweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+19.93%
+6.87%
+8.34%
+14.68%
+3.24%
+25.66%
+3.63%
+26.46%
+23.4%
+12.55%
Average +14.48%
Weighted average by Cap. +11.37%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
341.11USD
Average target price
404.73USD
Spread / Average Target
+18.65%
High Price Target
459.00USD
Spread / Highest target
+34.56%
Low Price Target
340.00USD
Spread / Lowest Target
-0.33%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. WST Stock
  4. Consensus West Pharmaceutical Services, Inc.